Therefore, it has also been suggested that the rhsTM inhibits the binding of β1 integrin of human breast cancer-derived cell lines to fibronectin, but we have not demonstrated whether rhsTM has the same effect as TMD123-Fc in the current study. This evidence concerns the gene FN1 and breast carcinoma.